Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status
Transcatheter aortic valve implantation (TAVI) is the standard of care for symptomatic severe aortic stenosis. Antithrombotic therapy is required after TAVI to prevent thrombotic complications but it increases the risk of bleeding events. Current clinical guidelines are mostly driven by expert opini...
Saved in:
| Main Authors: | Antonio Greco, Davide Capodanno |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2020-04-01
|
| Series: | Interventional Cardiology: Reviews, Research, Resources |
| Online Access: | https://www.icrjournal.com/articleindex/icr.2019.24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Paravalvular leak after transcatheter aortic valve implantation
by: Orhan Gökalp, et al.
Published: (2020-08-01) -
THE PROGNOSIS IN TRANSCATHETER AORTIC VALVE IMPLANTATION
by: T. E. Imaev, et al.
Published: (2017-01-01) -
Transcatheter aortic valve-in-ring implantation after aortic valve repair and annuloplastyCentral Message
by: Sandeep N. Bharadwaj, MD, et al.
Published: (2024-04-01) -
Acute Kidney Injury after Transcatheter Aortic Valve Implantation
by: L. V. Kremneva, et al.
Published: (2022-07-01) -
Platypnea-Orthodeoxia Syndrome after Transcatheter Aortic Valve Implantation
by: Andrew K. Roy, et al.
Published: (2016-01-01)